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Introduction {#sec1}
============

Brown adipose tissue (BAT) specializes in the regulated production of heat, also known as "adaptive" or "non-shivering" thermogenesis ([@bib3]). To fulfill this function, BAT is rich in mitochondria and expresses the mitochondrial uncoupling protein 1 (Ucp1). Upon exposure to cold, local release of the adrenergic agonist norepinephrine (NE) induces thermogenesis by activating Ucp1, which generates heat by dissipating the mitochondrial proton gradient and allowing high rates of substrate oxidation. The capacity of BAT to convert stored chemical energy to heat is important for the defense of body temperature in cold environments and may also serve to expend energy at times of caloric excess, as in "diet-induced thermogenesis," and thus counteract obesity ([@bib3]). Importantly, the thermogenic capacity of BAT shows plasticity: it can be expanded in response to repeated or prolonged exposure to cold or attenuated and even lost in response to thermoneutral environments, aging, obesity, or denervation of the tissue ([@bib10], [@bib34], [@bib37], [@bib53]). Although it is well recognized that adrenergic stimulation is the main signal that drives the expansion of thermogenic capacity, the transcription factors that transform this signal into long-term adaptive changes in energy expenditure remain poorly defined.

The estrogen-related receptors (ERRα, ERRβ, and ERRγ) are closely related members of the nuclear receptor family. They have no known endogenous ligands and, despite their name, do not bind estrogen ([@bib15]). Several features of ERRs suggest that these receptors could play important roles in the adrenergic-driven remodeling of BAT. First, they are highly and preferentially expressed in BAT vs. white adipose tissue (WAT), with ERRα being the most abundant, followed by ERRγ and then ERRβ ([@bib2], [@bib13]). Second, ERRs are strongly activated by PGC-1α and Gadd45γ, two regulators that are induced by cold in BAT ([@bib13], [@bib36]). Finally, ERRs directly regulate the transcription of genes important for oxidative and thermogenic capacity. ERRα controls genes encoding factors of mitochondrial biogenesis, tricarboxylic acid (TCA) cycle, lipid oxidation, and angiogenesis ([@bib1], [@bib22], [@bib20], [@bib32], [@bib38]). ERRγ shares many ERRα targets and when overexpressed can induce Ucp1 expression and oxidative capacity in brown adipocytes ([@bib8], [@bib9], [@bib13]). However, whole-body ERRα KO mice show no defects in the transcriptional response to adrenergic stimulation, even though they have decreased BAT mitochondrial content and are sensitive to cold ([@bib29], [@bib43]). The physiological roles of ERRγ or ERRβ in BAT are not known.

To address the role of adipose ERRs in BAT physiology and specifically the transcriptional remodeling that takes place in response to adrenergic stimulation, we have generated adipose tissue-specific knockout mice lacking different combinations of ERRs. Because young mice grown at regular vivarium temperatures need BAT function to effectively defend their body temperature, we have bred and raised WT and ERR^Ad−/−^ at thermoneutrality. This approach minimizes confounding factors such as increased adrenergic tone in mice that have BAT defects ([@bib40]). Here, we show that mice lacking either ERRα alone or both ERRβ and ERRγ in adipose tissue have minor changes in their BAT, whereas mice lacking ERRα and ERRγ (the two main isoforms in BAT) have severe defects in oxidative and thermogenic capacity. Remarkably, when mice are treated with a β~3~-adrenergic agonist, the transcriptional response of BAT is virtually entirely dependent on ERRs. Mice lacking adipose ERRα and ERRγ also fail to enhance their oxidative and thermogenic capacity, even though adrenergic cytoplasmic signaling is preserved. Our findings show that ERRs are essential for BAT remodeling in response to adrenergic stimulation and suggest that ERR activation may sensitize BAT to adrenergic signals and lead to increased energy expenditure.

Results {#sec2}
=======

ERRs Act Collectively and in a Redundant Manner to Protect BAT Oxidative Capacity *In Vivo* {#sec2.1}
-------------------------------------------------------------------------------------------

We recently showed that ERRs act redundantly to preserve mitochondrial function in primary brown adipocytes ([@bib14]), suggesting that ERRs may collectively control brown adipocyte oxidative and thermogenic function *in vivo*. To test this notion, we generated three lines of mice lacking different combinations of ERRs specifically in adipose tissue: mice lacking just ERRα, the most abundant ERR in adipose tissue (ERRα^Ad−/−^); mice lacking ERRβ and ERRγ, the two ERRs that are highly enriched in BAT compared with WAT (ERRβγ^Ad−/−^); and mice that lack ERRα and ERRγ, the two most abundant ERRs in BAT and WAT (ERRαγ^Ad−/−^) ([@bib8], [@bib13]). To minimize the effect of thermal stress at standard vivarium temperatures, all mice were born and raised at thermoneutrality (30°C). Loss of ERRs in BAT was confirmed at the mRNA level for all three isoforms ([Figure 1](#fig1){ref-type="fig"}A) and at the protein level for ERRα and ERRγ ([Figure 1](#fig1){ref-type="fig"}B); ERRβ protein could not be detected reliably in WT BAT with currently available antibodies. Decreases in ERR mRNA were also observed in inguinal WAT, but not skeletal muscle, confirming that the adiponectin promoter-driven knockout was tissue specific ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). Notably, ERRβ mRNA was nearly undetectable in the BAT of ERRαγ^Ad−/−^ mice, suggesting that double knockout of ERRα and ERRγ results in the practical loss of all three ERRs ([Figure 1](#fig1){ref-type="fig"}A). We next measured the mRNA levels in BAT of known ERR target genes involved in the TCA cycle and oxidative phosphorylation (OxPhos; [@bib9], [@bib38], [@bib43]). Loss of ERRα alone (ERRα^Ad−/−^) showed decreases in many but not all of these genes, whereas loss of ERRβ and ERRγ (ERRβγ^Ad−/−^) had no significant effect ([Figure 1](#fig1){ref-type="fig"}C). However, the parallel loss of ERRα and ERRγ (ERRαγ^Ad−/−^) resulted in larger decreases and in all tested ERR targets, consistent with ERRs complementing each other in regulating gene expression in BAT ([Figure 1](#fig1){ref-type="fig"}C). Similarly, ERRα^Ad−/−^ and ERRβγ^Ad−/−^ mice showed minor defects in BAT OxPhos protein and mtDNA content, but ERRαγ^Ad−/−^ mice displayed a dramatic loss of BAT OxPhos complexes I--IV and a ∼60% reduction in mtDNA content ([Figures 1](#fig1){ref-type="fig"}D--1F). These data show that ERRs display robust redundancy in protecting BAT oxidative capacity *in vivo*. Thus, to test the collective role of ERRs in adipose tissue function, we focused on studying BAT function in the ERRαγ^Ad−/−^ mice, which showed pronounced defects in oxidative capacity.Figure 1ERRs Act Collectively and in a Redundant Manner to Promote BAT Mitochondrial Oxidative Capacity(A) Relative ERR mRNA levels in BAT from WT or littermate mice with adipose-specific deletions of ERRα (ERRα^Ad−/−^), ERRβ and ERRγ (ERRβγ^Ad−/−^), or ERRα and ERRγ (ERRαγ^Ad−/−^), expressed relative to the levels of each gene in WT BAT and normalized to *Ppia*. Numbers above bars represent Ct (threshold cycle) values for each ERR isoform in WT BAT.(B) Western blot of ERRα, ERRγ, and RAN (ras-related nuclear protein; loading control).(C) Relative mRNA levels of genes acting in the tricarboxylic acid (TCA) cycle and/or oxidative phosphorylation (OxPhos) and normalized to *Ppia*.(D) Representative western blot of OxPhos complexes I--V and RAN (loading control) protein.(E) Quantification of OxPhos complexes, based on blots of panel D (expressed relative to levels in WT BAT and normalized to RAN protein).(F) Relative mitochondrial DNA (mtDNA) copy number, normalized to gDNA in BAT of the same mice.(A--F) Mice were born and raised at thermoneutrality (30°C) and euthanized at 12 weeks of age. Data are mean ± SD of 14 WT, 4 ERRα^Ad−/−^, 6 ERRβγ^Ad−/−^, and 5 ERRαγ^Ad−/−^ mice. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT BAT. WT data in panels A, C, E, and F are the accrued data of all WT littermates of ERRα floxed, ERRβγ floxed, and ERRαγ floxed mice. There were no differences between WT mice of the different cohorts. The same loading control (RAN) is presented in panels B and D. See also [Figure S1](#mmc1){ref-type="supplementary-material"}, [Table S3](#mmc1){ref-type="supplementary-material"}.

Loss of ERRα and ERRγ Impairs BAT Thermogenic Capacity without Affecting Adipogenesis or BAT Identity {#sec2.2}
-----------------------------------------------------------------------------------------------------

BAT is characterized by its brown color, the presence of small multilocular lipid droplets, a high density of mitochondria, and the expression of Ucp1 ([@bib3]). In mice lacking adipose ERRα and ERRγ, the interscapular BAT depot was paler than WT BAT ([Figure 2](#fig2){ref-type="fig"}A) and showed notably increased lipid accumulation ([Figure 2](#fig2){ref-type="fig"}B). Electron microscopy imaging revealed sparse BAT mitochondria that were often malformed and with few visible cristae ([Figure 2](#fig2){ref-type="fig"}C). The abnormal mitochondrial structure was coupled with decreased expression of genes important for mitochondrial morphology and cristae structure ([Figure 2](#fig2){ref-type="fig"}D). Importantly, loss of adipose ERRs did not result in decreased expression of markers of BAT differentiation (*Prdm16*, *Zic1*, *Lhx8, Ebf2*) or adipogenesis (*Pparg*, *Fabp4*), indicating that the lipid accumulation and changes in mitochondria were not secondary to defects in the program of development or differentiation of BAT ([Figure 2](#fig2){ref-type="fig"}E). In support of the dramatic decrease in expression of TCA genes and OxPhos complexes I--IV shown in [Figure 1](#fig1){ref-type="fig"}, other genes of these pathways were also significantly reduced (*Cox7a1* and *Cs*) in ERRαγ^Ad−/−^ BAT ([Figure 2](#fig2){ref-type="fig"}F). ERRαγ^Ad−/−^ BAT also displayed decreased expression of genes important for fatty acid oxidation ([Figure 2](#fig2){ref-type="fig"}G) and increased expression of genes that regulate fatty acid biosynthesis and storage ([Figure 2](#fig2){ref-type="fig"}H), which may contribute to the increase in lipid accumulation. Additional lipid metabolism genes and other pathways, such as creatine metabolism, were also altered in ERRαγ^Ad−/−^ mice ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). Finally, the expression of two hallmark genes essential for thermogenesis, *Ucp1* and *Dio2,* was severely defective in BAT of ERRαγ^Ad−/−^ mice ([Figure 2](#fig2){ref-type="fig"}I). Ucp1 protein levels were also dramatically decreased ([Figure 2](#fig2){ref-type="fig"}J), in a manner consistent again with largely redundant roles of ERRs ([Figure S2](#mmc1){ref-type="supplementary-material"}C). The decreased Ucp1 expression suggested that thermogenic activity would be greatly reduced. Indeed, when exposed to 4°C, ERRαγ^Ad−/−^ mice were very cold intolerant and became hypothermic in less than 2.5 hr ([Figure 2](#fig2){ref-type="fig"}K). These findings show that adipose ERRs are required to maintain proper oxidative and thermogenic capacity in BAT and to defend body temperature upon acute cold exposure.Figure 2Loss of ERRα and ERRγ Impairs BAT Thermogenic Capacity without Affecting Adipogenesis or BAT Identity(A) Gross morphology of interscapular BAT depots from WT and ERRαγ^Ad−/−^ mice.(B) H&E staining of BAT at 400× magnification.(C) Electron microscopy of mitochondria and surrounding lipid droplets in BAT. L, lipid droplet.(D--I, L, and M) Relative mRNA levels of genes involved in mitochondrial morphology and cristae structure (D), adipogenesis and BAT identity (E), OxPhos and TCA cycle (F), fatty acid (FA) oxidation (G), FA biosynthesis and storage (H), thermogenesis (I), nuclear regulation of the mitochondrial oxidative metabolism program (L), and mitochondrial regulation of mitochondrial biogenesis (M).(J) Western blot of Ucp1 protein and RAN (loading control).(K) Body temperature of WT and ERRαγ^Ad−/−^ female mice either at 30°C or moved from 30°C to 4°C for 2.5 hr (n = 5). \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT 4°C.Mice were born and raised at thermoneutrality (30°C) and euthanized at 12 weeks of age. mRNA data are from male and female mice combined and normalized to *Ppia* (n = 7--18). Protein data shown here are from male mice. Data are mean ± SEM. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT BAT. See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

To gain insights into the level at which ERRs control mitochondrial content and thermogenic function, we next assessed the expression levels of other transcriptional regulators of oxidative metabolism and thermogenesis genes. The two nuclear transcriptional co-regulators that drive mitochondrial biogenesis and *Ucp1* expression in BAT, *Ppargc1a* and *Ppargc1b* ([@bib36], [@bib41]), were moderately up- and down-regulated, respectively, at the mRNA level ([Figure 2](#fig2){ref-type="fig"}L); assessment of their protein expression showed a trend for both co-regulators to be at higher levels in ERRαγ^Ad−/−^ than WT BAT ([Figure S2](#mmc1){ref-type="supplementary-material"}D). The mRNA levels of other regulators of BAT oxidative capacity and *Ucp1* were not altered (*Nrf1* and *Gadd45γ*), moderately (∼20%) decreased (*Gabpa*), or increased (*Irf4*) ([Figure 2](#fig2){ref-type="fig"}L). The small changes in the expression of these regulators are thus unlikely to explain the dramatic loss of mitochondrial structure and proteins. On the other hand, we observed decreases in the expression of nuclear genes that encode regulators of mtDNA expression, such as *Tfam*, *Tfb2m*, *Polrmt*, and most notably the ERR targets *Sirt3* and *Endog* ([@bib16], [@bib31]; [Figure 2](#fig2){ref-type="fig"}M), suggesting that the loss of ERRs is sufficient to compromise expression of genes important for mitochondrial biogenesis and thermogenesis even when other known nuclear transcriptional regulators of these programs are largely unaffected.

Adipose ERRs Are Essential for the Remodeling of BAT Induced by β~3~-Adrenergic Agonists {#sec2.3}
----------------------------------------------------------------------------------------

Adrenergic stimulation of BAT promotes tissue remodeling by enhancing mitochondrial biogenesis and *Ucp1* expression, thereby increasing long-term oxidative and thermogenic capacity ([@bib3]). To determine if ERRs are required for BAT remodeling in response to adrenergic stimulation, mice were injected with the β~3~-specific adrenergic agonist CL316,243 or PBS as a control, for 10 days. As expected, WT mice treated with CL316,243 had darker BAT depots ([Figure 3](#fig3){ref-type="fig"}A; lower left panel) and decreased lipid accumulation, relative to WT mice treated with PBS ([Figure 3](#fig3){ref-type="fig"}B; lower left panel). These responses to CL316,243 treatment were completely dependent on ERRs, as PBS- and CL316,243-treated ERRαγ^Ad−/−^ mice had similar pale color and high lipid content in their BAT depots ([Figures 3](#fig3){ref-type="fig"}A and 3B). Moreover, CL316,243 treatment resulted in mitochondrial changes, such as increased cristae density, in WT but not in ERRαγ^Ad−/−^ mice ([Figure 3](#fig3){ref-type="fig"}C). Instead, mitochondria from ERRαγ^Ad−/−^ mice treated with CL316,243 appeared to form abnormal circle-shaped cristae structures ([Figure 3](#fig3){ref-type="fig"}C; lower right panel). mtDNA content increased upon CL316,243 treatment in both WT and ERRαγ^Ad−/−^ mice but remained very low in ERRαγ^Ad−/−^mice ([Figure 3](#fig3){ref-type="fig"}D). In WT BAT, CL316,243 treatment also elicited greater than 2-fold increases in protein expression of OxPhos complexes I and II and smaller but significant increases in complexes III and IV. These increases were considerably blunted in the BAT of ERRαγ^Ad−/−^ mice ([Figures 3](#fig3){ref-type="fig"}E and 3F). Finally, the ability of CL316,243 to induce Ucp1 protein ([Figure 3](#fig3){ref-type="fig"}G) and *Ucp1* mRNA ([Figure 3](#fig3){ref-type="fig"}H) in WT BAT was largely lost in the BAT of ERRαγ^Ad−/−^ mice. Notably, the defects in the response to CL316,243 were not due to impaired adrenergic signaling. Primary brown adipocytes isolated from ERRαγ^Ad−/−^ mice displayed full induction of hormone-sensitive lipase (HSL) phosphorylation and of lipolysis upon NE or CL316,243 stimulation ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Moreover, acute treatment of mice with CL316,243 induced the phosphorylation of HSL, the MAPK p38, and the transcription factor ATF2 in ERRαγ^Ad−/−^ mice ([Figures S3](#mmc1){ref-type="supplementary-material"}C and S3D). Finally, CL316,243 induced lipolysis in ERRαγ^Ad−/−^ BAT explants as efficiently, if not better than in WT BAT explants ([Figure S3](#mmc1){ref-type="supplementary-material"}E).Figure 3Effect of 10 Days\' Treatment with CL316,243 on BAT of WT and ERRαγ^Ad−/−^ Mice(A) Gross morphology of interscapular BAT from WT and ERRαγ^Ad−/−^ mice. Upper panel: PBS (before and after dissection from surrounding WAT). Lower panel: CL316,243 (before and after dissection from surrounding WAT).(B) H&E staining of BAT at 400× magnification.(C) Electron microscopy of mitochondria and surrounding lipid droplets in BAT. L, lipid droplet; arrows point to abnormal cristae formations.(D) Relative mtDNA copy number, normalized to gDNA (n = 9--19).(E) Representative western blot of OxPhos complexes I--V, ERRα, ERRγ, and RAN (loading control).(F) Quantification of OxPhos western blots, normalized to RAN protein levels (n = 6--9).(G) Representative western blot of Ucp1 protein and RAN (loading control).(H) *Ucp1* mRNA, normalized to *Ppia* mRNA (n = 6--7).Male mice were born and raised at thermoneutrality (30°C), treated with PBS or CL316,243 for 10 days, and euthanized at 12 weeks of age. Data are mean ± SEM \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT in the same treatment; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 vs. PBS in the same genotype. The same loading control (RAN) is presented in panels E and G. See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

To obtain an unbiased view of the contribution of ERRs to the β~3~-adrenergic-induced remodeling of BAT, we next used RNA sequencing to compare the global transcriptional changes induced by 10 days of CL316,243 treatment in WT and ERRαγ^Ad−/−^ BAT depots. CL316,243 enhanced the expression of 1,024 genes in WT mice but only 352 genes in ERRαγ^Ad−/−^ mice (applying cut-offs of 1.5-fold increase and p \< 0.05; [Figures 4](#fig4){ref-type="fig"}A and 4B). Strikingly, only 219 of the 1,024 genes induced by CL316,243 in WT mice were significantly induced in ERRαγ^Ad−/−^ BAT depots, showing that ERRs are required for the vast majority (∼80%) of the transcriptional adaptation to chronic β~3~-adrenergic stimulation ([Figures 4](#fig4){ref-type="fig"}A and 4B). Moreover, the absolute levels of 109 of the 219 genes induced in both WT and KO mice were significantly lower in ERRαγ^Ad−/−^ BAT relative to WT BAT ([Figures 4](#fig4){ref-type="fig"}Aii and 4Bii). Overall, ∼89% of the genes induced by CL316,243 in WT BAT were dependent on ERRs for their full induction. Pathway analyses of the differentially expressed genes identified "mitochondrial dysfunction" and "oxidative phosphorylation" as the top two canonical pathways regulated by CL316,243 in WT BAT; neither of these pathways was significantly regulated by CL316,243 in ERRαγ^Ad−/−^ BAT ([Table 1](#tbl1){ref-type="table"}). Of the top pathways regulated by CL316,243 in WT BAT, "Fatty-acid β-oxidation" remained preserved and became the top regulated pathway in ERRαγ^Ad−/−^ BAT ([Tables 1](#tbl1){ref-type="table"} and [S1](#mmc1){ref-type="supplementary-material"}). Thus the loss of ERRs selectively altered the nature of the CL316,243-induced response by affecting specific and highly regulated pathways, rather than just attenuating CL316,243-induced responses across all pathways. Notably, the role of ERRs in the CL316,243-induced transcriptional remodeling extended beyond the predicted regulation of mitochondrial, OxPhos, and TCA cycle genes. Among the 20 genes highest induced by CL316,243 in WT BAT, 14 genes rely on ERRs for their induction and these include genes of lipid, phospholipid, and glycosphingolipid synthesis, as well as signaling proteins, a K+ channel, a carbonic anhydrase, and proteins of unknown function ([Figure S4](#mmc1){ref-type="supplementary-material"}A).Figure 4Analyses of RNA Sequencing Data of BAT of WT and ERRαγ^Ad−/−^ Mice Treated with CL316,243(A) Heat maps of genes significantly induced (p \< 0.05) by CL316,243 in WT and ERRαγ^Ad−/−^ BAT, using a 1.5-fold cut-off. Minimum and maximum log transformed values are −9 and 6, respectively, with visual contrasts set to 2. (i) Genes induced significantly by CL316,243 in WT BAT only. (ii) Genes induced by CL316,243 in both WT and ERRαγ^Ad−/−^ BAT, but expression is significantly higher in WT CL316,243 vs. ERRαγ^Ad−/−^ CL316,243. (iii) Genes induced by CL316,243 in both WT and ERRαγ^Ad−/−^ mice. (iv) Genes induced by CL316,243 in ERRαγ^Ad−/−^ BAT only.(B) Venn diagram of genes significantly induced (p \< 0.05) by CL316,243 in BAT. Sections i--iv correspond with genes displayed in heat maps (A).(C) Heat maps of genes significantly reduced (p \< 0.05) in ERRαγ^Ad−/−^ vs. WT BAT, in PBS- and/or CL316,243-treated mice, using a 1.5-fold cut-off. Minimum and maximum log transformed values were −5 and 6, respectively, with visual contrasts set to 2. (i) Genes reduced in PBS-treated mice only. (ii) Genes reduced in both PBS- and CL316,243-treated ERRαγ^Ad−/−^ mice. (iii) Genes reduced in CL316,243-treated ERRαγ^Ad−/−^ mice only.(D) Venn diagrams of genes significantly reduced (p \< 0.05) in ERRαγ^Ad−/−^ BAT. Sections i--iii correspond with genes displayed in heat maps (C).Male mice were born and raised at thermoneutrality (30°C), treated with PBS or CL316,243 for 10 days, and euthanized at 12 weeks of age (n = 3). See also [Figure S4](#mmc1){ref-type="supplementary-material"} and [Tables 1](#tbl1){ref-type="table"}, [S1](#mmc1){ref-type="supplementary-material"}, and [S2](#mmc1){ref-type="supplementary-material"}.Table 1Top Canonical Pathways Regulated by CL316,243 in WT BAT and Their Ranking in ERRαγ^Ad−/−^ BATCanonical PathwayWT MiceERRαγ^Ad−/−^ MiceRankDownregulatedUpregulated-log(p Value)RankDownregulatedUpregulated-log(p Value)Mitochondrial dysfunction18/142 (6%)79/142 (56%)9.29E+00NAOxidative phosphorylation22/85 (2%)62/85 (73%)8.92E+00NATCA cycle II (eukaryotic)30/19 (0%)17/19 (89%)7.22E+00270/19 (0%)13/19 (68%)2.03E+00Fatty acid β-oxidation I40/26 (0%)16/26 (62%)6.80E+0010/26 (0%)21/26 (81%)8.28E+00Glutaryl-CoA degradation51/15 (7%)11/15 (73%)6.66E+00391/15 (7%)11/15 (73%)1.72E+00Tryptophan degradation III (eukaryotic)61/15 (7%)11/15 (73%)6.66E+00401/15 (7%)11/15 (73%)1.72E+00Valine degradation I70/17 (0%)13/17 (76%)5.81E+0080/17 (0%)15/17 (88%)4.01E+00Acetyl-CoA biosynthesis I (pyruvate dehydrogenase complex)80/5 (0%)5/5 (100%)4.34E+002150/5 (0%)3/5 (60%)5.08E-01Allograft rejection signaling911/19 (58%)0/19 (0%)4.23E+00512/19 (63%)0/19 (0%)4.60E+00LXR/RXR activation1013/64 (20%)16/64 (25%)4.20E+001517/64 (27%)8/64 (13%)2.76E+00Autoimmune thyroid disease signaling119/13 (69%)0/13 (0%)4.12E+00308/13 (62%)1/13 (8%)1.95E+00Isoleucine degradation I121/13 (8%)9/13 (69%)4.12E+00691/13 (8%)11/13 (85%)1.21E+00Complement system1313/23 (57%)1/23 (4%)4.11E+00314/23 (61%)2/23 (9%)6.83E+00Antigen presentation pathway1411/24 (46%)1/24 (4%)3.90E+00417/24 (71%)1/24 (4%)5.58E+00Gluconeogenesis I152/17 (12%)10/17 (59%)3.88E+001046/17 (35%)3/17 (18%)9.28E-01[^5]

To gain insights into the global roles of BAT ERRs, we next analyzed the RNA-sequencing data to define genes and pathways whose expression is affected by ERRs, by comparing WT and ERRαγ^Ad−/−^ BAT of PBS- or CL316,243-treated mice ([Figures 4](#fig4){ref-type="fig"}C and 4D). The top ERR-regulated pathways were "oxidative phosphorylation," "mitochondrial dysfunction," and "TCA cycle," i.e., the same pathways that were induced by CL316,243 in WT BAT ([Tables S2](#mmc1){ref-type="supplementary-material"} and [1](#tbl1){ref-type="table"}). Notably, a heatmap representation of ERR-dependent gene expression shows that the levels of many of these genes were enhanced by CL316,243 in WT BAT ([Figure 4](#fig4){ref-type="fig"}C). Furthermore, ERRs affected the expression of a broader set of genes in CL316,243-treated than in PBS-treated mice, suggesting that ERR signaling was enhanced by the β~3~-adrenergic agonist ([Figure 4](#fig4){ref-type="fig"}D). In summary, there was a high correlation between ERR dependency and CL316,243 induction of gene expression, consistent with the notions that (1) the majority of the transcriptional changes induced by CL316,243 require ERRs and (2) ERR signaling is enhanced by CL316,243.

ERRs Contribute to the CL316,243-Induced Browning of Inguinal WAT {#sec2.4}
-----------------------------------------------------------------

In addition to its effects on BAT, β~3~-adrenergic stimulation leads to the appearance of brown-like adipocytes in inguinal WAT (ingWAT), a process known as browning or beiging ([@bib17], [@bib18]). Therefore we assessed the ability of CL316,243 to induce browning of ingWAT in WT and ERRαγ^Ad−/−^ mice. CL316,243 treatment led to the prominent appearance of multilocular adipocytes in the ingWAT of WT mice but had minimal effects on the adipocytes of the ingWAT of ERRαγ^Ad−/−^ mice ([Figure 5](#fig5){ref-type="fig"}A). CL316,243 also significantly increased the protein levels of all five OxPhos complexes in WT ingWAT ([Figures 5](#fig5){ref-type="fig"}B and 5C), a response that was blunted in ERRαγ^Ad−/−^ mice. Similarly, CL316,243 treatment dramatically induced Ucp1 protein and mRNA in WT ingWAT (nearly 100-fold) but had notably more modest effects (∼10-fold) on *Ucp1* expression in ERRαγ^Ad−/−^ ingWAT ([Figures 5](#fig5){ref-type="fig"}D and 5E). Similarly blunted responses to CL316,243 were seen for several other genes involved in the TCA and OxPhos ([Figure 5](#fig5){ref-type="fig"}F). The reduced response to CL316,243 was not due to impaired β~3~-adrenergic signaling, as primary inguinal white adipocytes isolated from these mice displayed full induction of HSL phosphorylation and lipolysis upon NE or CL316,243 stimulation ([Figure S5](#mmc1){ref-type="supplementary-material"}). In summary, the ingWAT of ERRαγ^Ad−/−^ mice showed impaired "browning," as assessed by histological analysis and measurements of mitochondrial protein and Ucp1 expression, suggesting that ERRs also contribute to the remodeling of ingWAT driven by β~3~-adrenergic signaling.Figure 5Effect of 10 Days\' Treatment with CL316,243 on ingWAT of WT and ERRαγ^Ad−/−^ Mice(A) H&E staining of inguinal white adipose tissue (ingWAT) at 400× magnification.(B) Representative western blot of OxPhos complexes I--V, ERRα, and RAN (loading control).(C) Quantification of OxPhos complex levels, normalized to RAN protein levels.(D) Western blot of Ucp1 protein and RAN (loading control).(E and F) mRNA levels of *Ucp1* and TCA/OxPhos genes, normalized to *Ppia* and expressed relative to levels in WT mice treated with PBS (n = 8--14).Mice are from the same experiment as in [Figure 3](#fig3){ref-type="fig"}. Data are mean ± SEM \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT in the same treatment; ^\#^p \< 0.05, ^\#\#^p \< 0.01, ^\#\#\#^p \< 0.001 vs. PBS in the same genotype. The same loading control (RAN) is presented in panels B and D. See also [Figure S5](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

Adipose ERRs Are Important for the Acute Enhancement of Whole-Body Metabolism by β-Adrenergic Stimulation {#sec2.5}
---------------------------------------------------------------------------------------------------------

Adrenergic activation of BAT enhances whole-body energy expenditure ([@bib49]). To determine the relative significance of adipose ERRs to whole-body metabolism, we tested the acute metabolic response of WT and ERRαγ^Ad−/−^ mice to adrenergic agonists, using indirect calorimetry. Notably, ERRαγ^Ad−/−^ and WT littermates treated with PBS showed no differences in oxygen consumption, body temperature, or respiratory exchange ratio (RER), suggesting that the decreased oxidative and thermogenic capacity of ERRαγ^Ad−/−^ mice is not important for whole-body metabolism in a thermoneutral, basal state ([Figures 6](#fig6){ref-type="fig"}A--6C and [S6](#mmc1){ref-type="supplementary-material"}A). An injection of CL316,243 led to a dramatic increase in oxygen consumption in WT mice but had a minimal effect, similar to injection of PBS, in ERRαγ^Ad−/−^ mice ([Figure 6](#fig6){ref-type="fig"}D), demonstrating that ERRs are required for the metabolic response to CL316,243. There were no differences in physical activity between the groups ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6D). Parallel to the increase in oxygen consumption, CL316,243 caused a small but significant and sustained (over ∼6 hr) increase in basal body temperature of WT mice that was not seen in ERRαγ^Ad−/−^ mice ([Figure 6](#fig6){ref-type="fig"}E). CL316,243 also led to a significant decrease in the RER of WT mice, consistent with increased lipid metabolism ([Figures 6](#fig6){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}C). The RER of CL316,243-treated ERRαγ^Ad-/-^ mice was not significantly different from that of WT and ERRαγ^Ad-/-^ mice injected with PBS ([Figure 6](#fig6){ref-type="fig"}C, [S6](#mmc1){ref-type="supplementary-material"}A, and S6C), although it is possible that a CL316,243-induced increase in adipose tissue lipolysis may have increased lipid utilization in other tissues, such as skeletal muscle. Interestingly, WT mice treated with CL316,243 for 10 days displayed a mild, but significant, increase in oxygen consumption even on the day after the injection (during the active phase, 32--44 hr after an injection \[[Figure 6](#fig6){ref-type="fig"}F\]), suggesting a prolonged effect of chronic β~3~-adrenergic stimulation on whole-body energy expenditure. Again, this was not seen in ERRαγ^Ad−/−^ mice. Overall, our data show that ERRs are required for the metabolic response to β~3~-adrenergic stimulation.Figure 6Metabolic Responses to Adrenergic Stimulation in WT and ERRαγ^Ad−/−^ Mice(A) Oxygen consumption (VO~2~) in WT and ERRαγ^Ad−/−^ mice injected with PBS for 10 days, on the last day of injections.(B) Core body temperature of WT and ERRαγ^Ad−/−^ mice injected with PBS for 10 days, on the last day of injections.(C) Average respiratory exchange ratio (RER) over 6 hr following a PBS or CL316,243 injection.(D) VO~2~ in WT and ERRαγ^Ad−/−^ mice injected with CL316,243 for 10 days, on the last day of injections.(E) Core body temperature of WT and ERRαγ^Ad−/−^ mice injected with CL316,243 for 10 days, on the last day of injections.(F) Average VO~2~ over the day and night on the day after the last PBS or CL316,243 injection (day, 20--32 hr after last injection; night, 32--44 hr after the last injection).(G) Acute VO~2~ response to norepinephrine (NE) in WT and ERRαγ^Ad−/−^ mice that had been treated with PBS for 10 days.(H) Acute VO~2~ response to NE in WT and ERRαγ^Ad−/−^ mice that had been treated with CL316,243 for 10 days.Male mice were born and raised at thermoneutrality (30°C), treated with PBS or CL316,243 for 10 days, and euthanized at 12--14 weeks of age. NE responses were tested 2 days after the last PBS or CL316,243 injection. Data are mean ± SEM (n = 5--10). \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001, WT vs. ERRαγ^Ad−/−^ for each condition; ^\#^p \< 0.05, ^\#\#^p \< 0.01 vs. WT PBS. ZT = zeitgeber time. Different mice were used for calorimetry and telemetry experiments. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

The β~3~-adrenergic agonist CL316,243 is a pharmacologic agent that acts selectively and potently on adipose tissue. To test the relative significance of ERRs in a more physiological context, we next compared the metabolic response of WT and ERRαγ^Ad−/−^ mice to the native agonist, NE, which activates a wider range of adrenergic receptors, including β~1~ and α~1~ types ([@bib33]). NE was administered to naive mice (treated with PBS), as well as to mice with "trained" BAT (treated with CL316,243 for 10 days). NE injection evoked significantly higher oxygen consumption rates in WT mice than in ERRαγ^Ad−/−^ mice, in both PBS- and CL316,243-treated groups ([Figures 6](#fig6){ref-type="fig"}G and 6H), showing that adipose ERRs are important for whole-body oxidative and thermogenic capacity in a physiological context. Furthermore, the difference in maximal oxygen consumption rates between WT and ERRαγ^Ad−/−^ mice treated with NE was more pronounced in mice that had received CL316,243 for 10 days relative to mice treated with PBS ([Figure S6](#mmc1){ref-type="supplementary-material"}E), supporting the notion that CL316,243-dependent remodeling of adipose tissues increased the thermogenic capacity in WT but not in ERRαγ^Ad−/−^ mice.

ERRs Are Required for CL316,243-Induced Weight Loss and Improved Glucose Tolerance in HFD Mice {#sec2.6}
----------------------------------------------------------------------------------------------

The mice studied earlier were fed a chow diet and were fairly lean. CL316,243 treatment induced a decrease in the adiposity of WT mice that was not seen in ERRαγ^Ad−/−^ mice, but it did not result in significant changes in body weight ([Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G). CL316,243 has been shown to confer greater metabolic improvements in mice fed a high-fat diet (HFD) compared with chow diet ([@bib49]). Hence, we next put WT and ERRαγ^Ad−/−^ mice on an HFD before evaluating the effects of CL316,243 treatment. WT and ERRαγ^Ad−/−^ mice had a similar food intake ([Figure S7](#mmc1){ref-type="supplementary-material"}A), and after 18 weeks on the HFD, similar body weights and glucose tolerance ([Figures 7](#fig7){ref-type="fig"}A and 7B). Subsequent treatment of the mice with CL316,243 (14 injections over 4 weeks, given every other day, since we observed sustained effects of CL316,243 on energy expenditure \[[Figure 6](#fig6){ref-type="fig"}F\]) led to significantly higher body weight loss in WT mice than in ERRαγ^Ad−/−^ mice ([Figures 7](#fig7){ref-type="fig"}C and 7D), with WT mice losing on average ∼20% and ERRαγ^Ad−/−^ mice losing just 3.7% of their body weight. CL316,243 treatment also improved glucose tolerance in WT mice ([Figure 7](#fig7){ref-type="fig"}E) but had no effect in ERRαγ^Ad−/−^ mice ([Figure 7](#fig7){ref-type="fig"}F), revealing that adipose ERRs are required for the beneficial metabolic effects of β~3~-agonists.Figure 7Effect of Long-term Adrenergic Stimulation on Body Weight and Glucose Tolerance of HFD-fed WT and ERRαγ^Ad−/−^ Mice(A) Body weights of WT and ERRαγ^Ad−/−^ mice fed a 60% high fat diet (HFD) for 18 weeks (n = 12--18).(B) Glucose tolerance test (GTT) of WT and ERRαγ^Ad−/−^ mice fed a 60% HFD and before treatment. Values are presented as percentage of starting blood glucose (WT, 111.7 ± 6.1 mg/dL; ERRαγ^Ad−/−^, 107.1 ± 3.7 mg/dL; p = 0.52), (n = 12--18).(C) Body weights of WT and ERRαγ^Ad−/−^ mice before and after treatment with PBS or CL316,243 (n = 6--9). \*\*\*p \< 0.001.(D) Body weight loss of WT and ERRαγ^Ad−/−^ mice, expressed as percentage of body weight before treatment (n = 6--9). \*p \< 0.01; \*\*\*p \< 0.001.(E) GTT of WT mice treated with PBS or CL316,243. Values are presented as percentage of starting blood glucose (WT PBS, 74.3 ± 9.9 mg/dL; WT CL316,243, 99.4 ± 8.2 mg/dL; p = 0.074). (n = 6--9). \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001 vs. WT CL316,243.(F) GTT of ERRαγ^Ad−/−^ mice treated with PBS or CL316,243. Values are presented as percentage of starting blood glucose (ERRαγ^Ad−/−^ PBS, 79.9 ± 4.9 mg/dL; ERRαγ^Ad−/−^ CL316,243, 75.2 ± 6.2 mg/dL; p = 0.56) (n = 6--9).Female mice were born and raised at thermoneutrality (30°C) and fed a 60% HFD starting at weaning. At 22 weeks of age, mice were given an intraperitoneal injection of PBS or CL316,243 every other day for 4 weeks. Mice were euthanized at 26 weeks of age. Data are presented as mean ± SEM.

Discussion {#sec3}
==========

Deciphering the transcriptional networks that regulate BAT development and function is important for developing therapeutic strategies to increase energy expenditure via non-shivering thermogenesis for the treatment of obesity. In the last several years, there has been much progress in understanding transcriptional mechanisms that control the commitment of stem cells to the brown/beige preadipocyte lineage and/or the differentiation of preadipocytes to mature brown or beige adipocytes ([@bib30], [@bib47]). Once differentiated, however, brown adipocytes require additional signals and factors to maintain and expand their thermogenic capacity ([@bib3], [@bib35]). Notably, exposure to cold and pharmacologic administration of β~3~-adrenergic agonists can enhance the thermogenic capacity and/or energy expenditure in both rodents and humans ([@bib3], [@bib6], [@bib42], [@bib52]). We show here that ERRs perform a central and essential role in mature brown adipocytes in determining both the basal thermogenic capacity and the ability to expand this capacity. Although past studies revealed a role for ERRα in building the high basal mitochondrial content of BAT ([@bib43]), the current study provides multiple lines of evidence that highlight that ERRs, collectively, play a substantially more important role than previously appreciated. First, double deletion of ERRα and ERRγ in mature adipocytes resulted in an extreme loss of mitochondrial content, with the remaining mitochondria having abnormal cristae and overall morphology and almost no Ucp1 protein; in comparison, mice lacking just ERRα (the most abundant BAT ERR isoform) had a milder reduction in mitochondrial content, and their mitochondria had normal morphology, oxidative function, and Ucp1 expression ([@bib43]). Second, mice lacking adipose ERRα and ERRγ show remarkable defects in their adaptive response to adrenergic stimulation, failing to remodel their transcriptome, expand their thermogenic capacity, and attain the metabolic benefits of β~3~-adrenergic agonists.

ERRα and ERRγ have been shown to bind similar sites on the genome and to regulate overlapping sets of genes ([@bib9], [@bib20]), suggesting that a certain degree of redundancy in their action is to be expected. Recent studies have also highlighted the complimentary roles of ERRs in determining the oxidative capacity in primary brown adipocytes and in the heart ([@bib14], [@bib46]). Yet, the extent to which mice lacking either just ERRα (ERRα^Ad−/−^) or ERRβ and ERRγ together (ERRβγ^Ad−/−^) maintain their mitochondrial content and OxPhos levels, despite a substantial loss of total ERR protein, is surprising. This functional compensation is seen without an upregulation of the remaining ERR isoforms, suggesting that BAT, at least in young mice, expresses ERRs at much higher levels than necessary for maintaining basal oxidative function. It will be interesting to assess ERR expression in the BAT depots of mice and humans at different ages, to establish if this high ERR reserve diminishes with age, as BAT function declines.

A most striking finding in our study is the key role of ERRs in the adrenergic response of BAT. This was unexpected, based on studies of the ERRα KO mouse, which showed normal induction of gene expression in response to adrenergic stimulation ([@bib43]). Importantly, adrenergic signaling, judged by phosphorylation of HSL, p38, and ATF2 and induction of lipolysis, is intact in BAT lacking ERRs, suggesting that ERRs act downstream of such signals to effect the transcriptional changes elicited by adrenergic stimulation. ERRs likely integrate adrenergic signaling in more than one way. PGC-1α and PGC-1β, whose expression and/or activity are increased via cAMP, protein kinase A (PKA), and p38 signaling, are potent co-activators of all three ERRs ([@bib13], [@bib21], [@bib24], [@bib39]). Moreover, Gadd45γ, whose expression is also induced by adrenergic signaling in a cAMP- and PKA-dependent manner, activates p38 and ERRβ/γ-dependent transcription in a PGC-1 independent manner ([@bib13]). Notably, although the absence of ERRs does not block adrenergic signaling, it may lead to a partial activation of the pathway in the basal state. We observed higher levels of phospho-p38, phospho-ATF2, and PGC-1α in the absence of adrenergic stimulation. The underlying mechanisms are not clear.

Once activated, ERRs are likely direct positive regulators of many adrenergically induced genes. Although some of the pathways induced by β~3~-adrenergic agonism (e.g., mitochondrial function, oxidative phosphorylation, and TCA cycle) were known to be regulated by ERRs ([@bib19], [@bib44]), our RNA sequencing data show a much broader set of adrenergic responses, extending beyond the control of mitochondrial biogenesis, that rely on ERRs. Some of the highly induced genes, such as *Ucp1*, *Dio2*, and *Fndc5* ([Figure S4](#mmc1){ref-type="supplementary-material"}), have ERR response elements and are regulated by ERRs ([@bib7], [@bib8], [@bib14], [@bib48]), suggesting that others are also direct targets. Notably, there are adrenergically induced genes that are not dependent on ERRs, consistent with adrenergic signaling being intact, and ERRs not required for all components of the adrenergic response. In particular, the induction of the FAO pathway is retained. Ingenuity Pathway Analysis for regulators of the genes in the FAO pathway suggests that this may be due to *Pparα,* whose expression is increased by CL316,243 in the BAT of ERRαγ^Ad−/−^ mice, and *Klf15*, which is modestly increased in the BAT of ERRαγ^Ad−/−^ ([Figure S4](#mmc1){ref-type="supplementary-material"}). Even though the induction of FAO genes is retained, FAO is likely defective in ERRαγ^Ad−/−^ BAT, owing to the mitochondrial impairment. Finally and importantly, we do not expect that all genes and proteins whose expression is reduced in the BAT of ERRαγ^Ad−/−^ mice are direct ERR targets. Loss of mitochondria and mitochondria-derived signals, as well as of the further actions of direct ERR targets (e.g., a potential paracrine function of Fndc5), may contribute to the loss of adaptive responses to adrenergic stimulation. In addition, the decrease in mitochondrial content likely contributes to the post-translational loss of expression of many mitochondrial proteins whose stability requires proper localization, including Ucp1.

The thermogenic capacity of BAT can be harnessed to increase energy expenditure and counteract obesity and obesity-related metabolic dysfunction ([@bib28]). Consistent with this notion, when treated with the β~3~-adrenergic agonist CL316,243, WT mice increased their energy expenditure, lost weight, and showed improvements in glucose homeostasis. ERRαγ^Ad−/−^ littermates were defective in all three responses, demonstrating the importance of ERR-controlled pathways in adipose tissue for the effects of β~3~-adrenergic stimulation on energy balance. Nonetheless, ERRαγ^Ad−/−^ mice were not prone to obesity in the absence of CL316,243 administration, whether on chow or HFD diet. This was irrespective of gender, as similar findings were seen in female and male mice fed a HFD ([Figure S7](#mmc1){ref-type="supplementary-material"}). On the one hand, this finding is not surprising, because our studies were performed at thermoneutrality, when BAT receives minimal adrenergic stimulation ([@bib49]). Other mutant mice with BAT thermogenic defects are also not prone to obesity ([@bib11], [@bib26]). On the other hand, BAT thermogenic capacity has been proposed to be important for diet-induced thermogenesis, i.e., the ability to increase energy expenditure in response to caloric excess, as in HFD ([@bib12], [@bib25]). There can be many explanations as to why ERRαγ^Ad−/−^ mice do not show increased obesity. First, diet-induced thermogenesis, the basis of which is less well understood than cold-induced thermogenesis, may involve signals and pathways that are sufficiently retained in ERRαγ^Ad−/−^ mice. Second, minor differences in vivarium temperatures or in the length of time spent at thermoneutrality may explain the different outcomes seen with different models. In our study, mice were born, raised, and studied at thermoneutrality, to minimize the impact that standard vivarium temperatures have on mice with defective BAT ([@bib40]). Finally, the adrenergic system can be activated by stress, so additional differences in vivarium conditions housing may affect findings.

Even though loss of BAT may not always give rise to obesity, it is clear that increased BAT capacity, coupled to activation, as seen at standard vivarium temperatures for mice, can lead to protection from obesity ([@bib4]). Indeed, mice with increased adipose PGC-1α/ERRα signaling, as seen in mice lacking the tumor suppressor folliculin, show elevated oxidative metabolism, resistance to hypothermia, and protection from HFD-induced obesity ([@bib51]). Although ERRs are nuclear receptors with no known endogenous ligand, crystallography studies show that they are amenable to drug design, with hydrophobic pockets that can accommodate synthetic ligands ([@bib5], [@bib23], [@bib45]). Synthetic agonists, such as GSK4716, can enhance the activity of ERRβ and ERRγ ([@bib45], [@bib54]). Newer GSK4716-derived molecules can activate ERRγ and promote WAT browning ([@bib50]), although the specificity of these ligands has not been tested yet *in vivo*. Our findings suggest that pharmacological activation of ERRs may be beneficial by increasing brown (and beige) adipose tissue thermogenic capacity. Moreover, increased ERR activity may sensitize adipose tissues to the action of adrenergic agonists. The concept of using β~3~-adrenergic agonists to pharmacologically activate BAT in humans was floated long ago but has been difficult to apply ([@bib27]). Recently, mirabregon, a β~3~-adrenergic agonist used in the treatment of overactive bladder, was shown to activate BAT in humans, albeit at doses four times higher than that of the current US Food and Drug Administration--approved dose and with adverse effects on the cardiovascular system ([@bib6]). Administration of ERR agonists could prime the adipose tissue for a more effective response to β~3~-adrenergic agonism, thereby enabling the use of lower doses. Future studies will be needed to evaluate the potential of ERR agonists to enhance BAT thermogenesis and energy expenditure, alone or in combination with β~3~-adrenergic stimulation.

In conclusion, we have demonstrated that ERRs are critical transcriptional regulators that control adipose tissue plasticity and orchestrate the adaptive remodeling induced by adrenergic stimuli. Our findings underscore the potential of targeting ERRs to expand energy expenditure capacity, which may be harnessed for the treatment of metabolic disease.
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